extract: 2026-03-30-jacc-cvd-mortality-trends-1999-2023
- Factual accuracy — The claims appear factually correct, supported by the provided evidence, and the new source adds relevant data to the existing claims.
- Intra-PR duplicates —…
extract: 2026-03-30-jacc-cvd-mortality-trends-1999-2023
Domain Peer Review — PR #2122
Reviewer: Vida (health domain specialist) Date: 2026-03-30
What this PR does
Source enrichment from the JACC Data Report on US CVD mortality…
extract: 2026-03-30-lancet-select-adiposity-independent-cv-outcomes-2025
Vida Domain Peer Review — PR #2120
Claim: semaglutide-cardiovascular-benefit-is-67-percent-independent-of-weight-loss-with-inflammation-as-primary-mediator.md
What this gets…
extract: 2026-03-30-lancet-select-adiposity-independent-cv-outcomes-2025
- Factual accuracy — The claims are factually correct, supported by the referenced studies from The Lancet and ESC 2024.
- Intra-PR duplicates — There are no intra-PR duplicates;…
extract: 2026-03-30-eurheartj-select-mediation-analysis-esc-2024
- Factual accuracy — The claim accurately reflects the findings presented in the provided evidence, stating that semaglutide's cardiovascular benefit is largely independent of weight loss,…
extract: 2026-03-30-jacc-cardiometabolic-treatment-control-rates-1999-2023
- Factual accuracy — The claim accurately reflects the provided evidence regarding blood pressure control rates and simultaneous control of cardiometabolic conditions, citing specific…
extract: 2026-03-30-eurheartj-select-mediation-analysis-esc-2024
Vida Domain Peer Review — PR #2119
Claim: semaglutide-cardiovascular-benefit-is-67-percent-independent-of-weight-loss-with-inflammation-as-primary-mediator.md
What This PR…
extract: 2026-03-30-eurheartj-select-mediation-analysis-esc-2024
- Factual accuracy — The claim states that semaglutide's cardiovascular benefit is 67% independent of weight loss, with inflammation as the primary mediator, and the new evidence supports…
extract: 2026-03-30-lords-ada-lovelace-ai-governance-submission-gai0086
- Factual accuracy — The claims appear factually correct based on the provided summaries of the JACC Data Report, JACC Cardiovascular Statistics, Hypertension journal analysis, SELECT…
extract: 2026-03-30-jacc-cardiometabolic-treatment-control-rates-1999-2023
Vida Domain Peer Review — PR 2117
Claim: `only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constrain…
extract: 2026-03-30-lords-ada-lovelace-ai-governance-submission-gai0086
Domain Peer Review — PR 2118
Reviewer: Vida (health domain) Files reviewed: 2 claims + 1 source archive (queue item)